These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Risk factors and prevention of hepatocellular carcinoma]. Tanaka K Fukuoka Igaku Zasshi; 1997 Oct; 88(10):325-30. PubMed ID: 9432489 [No Abstract] [Full Text] [Related]
44. Risk factors of hepatocellular carcinoma--current status and perspectives. Gao J; Xie L; Yang WS; Zhang W; Gao S; Wang J; Xiang YB Asian Pac J Cancer Prev; 2012; 13(3):743-52. PubMed ID: 22631642 [TBL] [Abstract][Full Text] [Related]
45. Hepatitis C and B viruses, and their association with hepatocellular carcinoma in Egypt. Darwish MA; Issa SA; Aziz AM; Darwish NM; Soliman AH J Egypt Public Health Assoc; 1993; 68(1-2):1-9. PubMed ID: 7504048 [TBL] [Abstract][Full Text] [Related]
46. Prevention of hepatocellular carcinoma. Kew MC S Afr J Surg; 2011 Apr; 49(2):50-1, 86. PubMed ID: 21614973 [No Abstract] [Full Text] [Related]
47. Prevalence of antibodies to hepatitis C virus in patients with hepatocellular carcinoma in Austria. Baur M; Hay U; Novacek G; Dittrich C; Ferenci P Arch Virol Suppl; 1992; 4():76-80. PubMed ID: 1280509 [TBL] [Abstract][Full Text] [Related]
51. Hepatocellular carcinoma in HIV positive patients. Nunnari G; Berretta M; Pinzone MR; Di Rosa M; Berretta S; Cunsolo G; Malaguarnera M; Cosentino S; De Paoli P; Schnell JM; Cacopardo B Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1257-70. PubMed ID: 23047511 [TBL] [Abstract][Full Text] [Related]
52. Hepatocellular carcinoma: pathogenetic implications of the hepatitis delta virus. Oliveri F; Colombatto P; Derenzini M; Trere D; Papotti M; David E; Negro F; Bellati G; Ideo G; D'Aquino M Prog Clin Biol Res; 1993; 382():165-70. PubMed ID: 8389050 [No Abstract] [Full Text] [Related]
55. Hepatocellular carcinoma associated with chronic viral hepatitis. Aetiology, diagnosis and treatment. Dusheiko GM Br Med Bull; 1990 Apr; 46(2):492-511. PubMed ID: 2165844 [TBL] [Abstract][Full Text] [Related]
56. Viral pathogenesis of hepatocellular carcinoma in the United States. Liang TJ; Jeffers LJ; Reddy KR; De Medina M; Parker IT; Cheinquer H; Idrovo V; Rabassa A; Schiff ER Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256 [TBL] [Abstract][Full Text] [Related]
57. Etiology of primary liver cancer and the role of steroidal hormones. Trichopoulos D Cancer Causes Control; 1992 Jan; 3(1):3-5. PubMed ID: 1311211 [No Abstract] [Full Text] [Related]
59. Roles of long noncoding RNAs in hepatocellular carcinoma. Shi L; Peng F; Tao Y; Fan X; Li N Virus Res; 2016 Sep; 223():131-9. PubMed ID: 27374059 [TBL] [Abstract][Full Text] [Related]
60. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. Di Bisceglie AM; Simpson LH; Lotze MT; Hoofnagle JH J Clin Gastroenterol; 1994 Oct; 19(3):222-6. PubMed ID: 7528758 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]